Bristol Myers Squibb is launching a new ad for its blockbuster-in-waiting drug Zeposia as it focuses on a new future for those with ulcerative colitis (UC). | Bristol Myers Squibb is launching a new ad for its blockbuster-in-waiting drug Zeposia as it focuses on a new future for those with ulcerative colitis (UC).
